These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

136 related articles for article (PubMed ID: 9029409)

  • 1. Lack of permanent nigrostriatal dopamine deficit following 6-hydroxydopamine injection into the rat striatum. Short communication.
    Opacka-Juffry J; Ashworth S; Sullivan AM; Banati RB; Blunt SB
    J Neural Transm (Vienna); 1996; 103(12):1429-34. PubMed ID: 9029409
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sequential administration of GDNF into the substantia nigra and striatum promotes dopamine neuron survival and axonal sprouting but not striatal reinnervation or functional recovery in the partial 6-OHDA lesion model.
    Rosenblad C; Kirik D; Björklund A
    Exp Neurol; 2000 Feb; 161(2):503-16. PubMed ID: 10686072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of behavioral and neurodegenerative changes following partial lesions of the nigrostriatal dopamine system induced by intrastriatal 6-hydroxydopamine in the rat.
    Kirik D; Rosenblad C; Björklund A
    Exp Neurol; 1998 Aug; 152(2):259-77. PubMed ID: 9710526
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The antioxidant drink effective microorganism-X (EM-X) pre-treatment attenuates the loss of nigrostriatal dopaminergic neurons in 6-hydroxydopamine-lesion rat model of Parkinson's disease.
    Datla KP; Bennett RD; Zbarsky V; Ke B; Liang YF; Higa T; Bahorun T; Aruoma OI; Dexter DT
    J Pharm Pharmacol; 2004 May; 56(5):649-54. PubMed ID: 15142343
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glial cell line-derived neurotrophic factor (GDNF) gene delivery protects dopaminergic terminals from degeneration.
    Connor B; Kozlowski DA; Unnerstall JR; Elsworth JD; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2001 May; 169(1):83-95. PubMed ID: 11312561
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dopamine transporter function assessed by antisense knockdown in the rat: protection from dopamine neurotoxicity.
    Van Kampen JM; McGeer EG; Stoessl AJ
    Synapse; 2000 Sep; 37(3):171-8. PubMed ID: 10881039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. GDNF protects against 6-OHDA nigrostriatal lesion: in vivo study with microdialysis and PET.
    Opacka-Juffry J; Ashworth S; Hume SP; Martin D; Brooks DJ; Blunt SB
    Neuroreport; 1995 Dec; 7(1):348-52. PubMed ID: 8742486
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cyclosporin A attenuates the decrease in tyrosine hydroxylase immunoreactivity in nigrostriatal dopaminergic neurons and in striatal dopamine content in rats with intrastriatal injection of 6-hydroxydopamine.
    Matsuura K; Makino H; Ogawa N
    Exp Neurol; 1997 Aug; 146(2):526-35. PubMed ID: 9270064
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation between rotation in the 6-OHDA lesioned rat and dopamine loss in striatal and substantia nigra subregions.
    Olds ME; Jacques DB; Kopyov O
    Synapse; 2006 Jun; 59(8):532-44. PubMed ID: 16565974
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The corticostriatal system mediates the "paradoxical" contraversive rotation but not the striatal hyperexpression of Fos induced by amphetamine early after 6-hydroxydopamine lesion of the nigrostriatal pathway.
    Lopez-Martin E; Rozas G; Rodriguez J; Guerra MJ; Labandeira-Garcia JL
    Exp Brain Res; 1998 May; 120(2):153-63. PubMed ID: 9629957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between asymmetries in striatal dopamine release and the direction of amphetamine-induced rotation during the first week following a unilateral 6-OHDA lesion of the substantia nigra.
    Robinson TE; Noordhoorn M; Chan EM; Mocsary Z; Camp DM; Whishaw IQ
    Synapse; 1994 May; 17(1):16-25. PubMed ID: 8042143
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dopaminergic neuronal degeneration and motor impairments following axon terminal lesion by instrastriatal 6-hydroxydopamine in the rat.
    Lee CS; Sauer H; Bjorklund A
    Neuroscience; 1996 Jun; 72(3):641-53. PubMed ID: 9157311
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Modulation of dopaminergic and glutamatergic brain function: PET studies on parkinsonian rats.
    Pellegrino D; Cicchetti F; Wang X; Zhu A; Yu M; Saint-Pierre M; Brownell AL
    J Nucl Med; 2007 Jul; 48(7):1147-53. PubMed ID: 17574972
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Progressive degeneration of nigrostriatal dopamine neurons following intrastriatal terminal lesions with 6-hydroxydopamine: a combined retrograde tracing and immunocytochemical study in the rat.
    Sauer H; Oertel WH
    Neuroscience; 1994 Mar; 59(2):401-15. PubMed ID: 7516500
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Biochemical and immunocytochemical changes induced by intrastriatal 6-hydroxydopamine injection in the rat nigrostriatal dopamine neuron system: evidence for cell death in the substantia nigra.
    Ichitani Y; Okamura H; Nakahara D; Nagatsu I; Ibata Y
    Exp Neurol; 1994 Dec; 130(2):269-78. PubMed ID: 7867756
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dose- and sex-dependent effects of the neurotoxin 6-hydroxydopamine on the nigrostriatal dopaminergic pathway of adult rats: differential actions of estrogen in males and females.
    Murray HE; Pillai AV; McArthur SR; Razvi N; Datla KP; Dexter DT; Gillies GE
    Neuroscience; 2003; 116(1):213-22. PubMed ID: 12535954
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Delivery of a GDNF gene into the substantia nigra after a progressive 6-OHDA lesion maintains functional nigrostriatal connections.
    Kozlowski DA; Connor B; Tillerson JL; Schallert T; Bohn MC
    Exp Neurol; 2000 Nov; 166(1):1-15. PubMed ID: 11031079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The pesticide fipronil injected into the substantia nigra of male rats decreases striatal dopamine content: A neurochemical, immunohistochemical and behavioral study.
    Bharatiya R; Bratzu J; Lobina C; Corda G; Cocco C; De Deurwaerdere P; Argiolas A; Melis MR; Sanna F
    Behav Brain Res; 2020 Apr; 384():112562. PubMed ID: 32070689
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SK channel blockade reverses cognitive and motor deficits induced by nigrostriatal dopamine lesions in rats.
    Chen L; Deltheil T; Turle-Lorenzo N; Liberge M; Rosier C; Watabe I; Sreng L; Amalric M; Mourre C
    Int J Neuropsychopharmacol; 2014 Aug; 17(8):1295-306. PubMed ID: 24661728
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Running wheel exercise enhances recovery from nigrostriatal dopamine injury without inducing neuroprotection.
    O'Dell SJ; Gross NB; Fricks AN; Casiano BD; Nguyen TB; Marshall JF
    Neuroscience; 2007 Feb; 144(3):1141-51. PubMed ID: 17157992
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.